- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04575051
Hearing for Communication and Resident Engagement (HearCARE)
HearCARE: Hearing for Communication and Resident Engagement
Amplification is a well-established, evidence-based front-line treatment for those with impaired communication secondary to Age Related Hearing Loss (ARHL). ARHL is the most prevalent cause of communication impairment among older adults. The challenge in treating ARHL is identifying a care model that effectively promotes adherence to individualized-treatment recommendations allowing the end-user to self-manage hearing loss with appropriate support. This proposal compares the two most common models of care for ARHL provided to adults in assisted living/personal care communities. The Consult Model (i.e., usual care) is an acute care strategy, relying on a monthly Audiologist visit to the facility.
The Engage Model is a chronic care approach to support hearing loss self-management of ARHL. Engage includes (a) hearing screening for all residents, (b) an individualized communication plan for those with an identified hearing loss (e.g., one-to-one, group, telephone, television plans, hearing aid trouble shooting, communication strategies, etc.), (c) provision of simple, non-custom amplifiers, (d) referral to audiology if needed, and (e) ongoing support provided by trained personnel (Communication Facilitator) under the supervision of the audiologist.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The study is employing an open cohort stepped-wedge cluster randomized design with a phased, randomized roll out. The stepped wedge design is a useful design for the evaluation of complex health care interventions particularly when the intervention is believed to be beneficial with minimal risk. This design is increasingly being used to evaluate interventions involving health care delivery and has several advantages:
- allowing the clinical teams to roll out the intervention in a small number of facilities in a timely, systematic manner (interventions are not part of the research protocol)
- possibly increasing participation and buy-in since all facilities will eventually implement the intervention during the study
- possible increase in statistical power compared to a cluster randomized trial due to increase in data collection and within cluster comparisons.
Our intervention is applied at the facility level (cluster) but the primary outcomes are obtained at the resident level. In this open cohort design, all residents in a facility are identified to participate but some may leave the facility and others will move into the facility over the course of the study. The interventions are standard care at UPMC and are at the facility and individual level regardless of participation in the research project by any individual.
The 10 facilities participating in the study all currently receive the Consult Model of care. These same facilities are targeted to receive the Engage Model of care over the next three years as part of the standard care in these facilities. Residents enrolled in the study during any time period will be followed until the end of the study or until they are no longer a resident of the facility, whichever comes first. This implies that crossover to the intervention is not only at the facility level but also the resident level. Once the intervention is available at a facility, residents will be exposed to the intervention continuously regardless of enrollment for the study measures. The resident level outcomes of satisfaction with social participation and hearing-specific HRQoL will be measured every 5 months for the duration of the study. In addition, staff satisfaction and family burden will be surveyed every 5 months.
NOTE: The clinicaltrials.gov record was updated after data collection ended to correct the study arms and interventions. The study arms were originally and incorrectly documented in clinicaltrials.gov as the resident, caregiver, and staff cohorts rather than the interventions.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Pennsylvania
-
Pittsburgh, Pennsylvania, United States, 15260
- University of Pittsburgh
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Willingness to participate and
- Being a resident, staff member or family member of a resident at one of the participating Assisted Living/Personal Care Facilities.
Exclusion Criteria:
- Unwillingness to participate
- Not being a Resident, staff member or family member of a resident at one of eight Assisted Living/Personal Care Facilities.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: HearCARE (Consult+Engage)
Residents will be exposed to the Consult Model and the Engage Model.
|
The Consult Model (i.e., usual care) is an acute care strategy, relying on a monthly Audiologist visit to the facility.
The Engage Model is a chronic care approach to supportive hearing loss self-management of ARHL.
Engage includes (a) hearing screening for all residents, (b) an individualized communication plan for those with an identified hearing loss (e.g., one-to-one, group, telephone, television plans, hearing aid trouble shooting, communication strategies, etc.), (c) provision of simple, non-custom amplifiers, (d) referral to audiology if needed, and (e) ongoing support provided by trained personnel (Communication Facilitator) under the supervision of the audiologist.
|
|
Other: Consult Model
The Consult Model (i.e., usual care) is an acute care strategy, relying on a monthly Audiologist visit to the facility.
|
The Consult Model (i.e., usual care) is an acute care strategy, relying on a monthly Audiologist visit to the facility.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Satisfaction With Social Participation
Time Frame: Baseline (T0), at 5 (T1), 10 (T2), 15 (T3), 20 (T4) and 25 (T5) months
|
PROMIS Satisfaction with Participation in Discretionary Social Activities SF7a self-reported contentment with leisure interests and relationships with friends.
T- scores are provided ranging from 27 to 65.6 where higher scores indicate more satisfaction (50 indicates the population mean with a standard deviation of 10).
|
Baseline (T0), at 5 (T1), 10 (T2), 15 (T3), 20 (T4) and 25 (T5) months
|
|
Hearing-Specific Health-Related Quality of Life
Time Frame: Baseline, at 5, 10, 15, 20 and 25 months
|
Hearing Handicap Inventory for the Elderly captures social and emotional hearing handicap.
10 items with responses scored 0, 2, and 4 for 'No', 'Sometimes', and 'Yes'; min total score is 0 and maximum is 40.
Higher scores indicate worse impact of hearing difficulties on activities and participation.
|
Baseline, at 5, 10, 15, 20 and 25 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Family Burden
Time Frame: Baseline, at 5, 10, 15, 20 and 25 months
|
Zarit Burden Interview is a 4-item questionnaire that measures caregiver burden.
The 4 items each have responses ranging from 0='Never' to 4='Nearly Always'.
Item responses are summed to produce the total score that ranges from 0 to 16 with higher scores indicating more burden.
|
Baseline, at 5, 10, 15, 20 and 25 months
|
|
Staff Satisfaction
Time Frame: Baseline, at 5, 10, 15, 20 and 25 months
|
Michigan Organizational Assessment Questionnaire (MOAQ) is a 3-item questionnaire that measures satisfaction with one's job.
Items have responses ranging from 1='Agree Strongly' to 6='Disagree Strongly'.
The combined score is the average of the 3 items with one item reverse scored.
Higher scores indicate less satisfaction.
|
Baseline, at 5, 10, 15, 20 and 25 months
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Catherine Palmer, PhD, University of Pittsburgh
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- STUDY19120233
- HL-2019C1-16067 (Other Grant/Funding Number: PCORI)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
IPD Sharing Time Frame
IPD Sharing Access Criteria
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
- SAP
- CSR
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hearing Loss, Age-Related
-
Autifony Therapeutics LimitedCompletedAge-Related Hearing LossUnited States
-
Yilai ShuHangzhou PhecdaMed Co., Ltd.Not yet recruitingDeafness | Age Related Hearing LossChina
-
University Hospital, AngersCompletedPostural; Defect | Hearing Aid | Age-Related Hearing LossFrance
-
Concordia University, MontrealCanadian Institutes of Health Research (CIHR)CompletedAging | Age Related Hearing LossCanada
-
Pamukkale UniversityCompletedHearing Loss | Physical Disability | Vestibular Disease | Age Related Hearing LossTurkey
-
University Hospital, AngersRecruiting
-
The Hong Kong Polytechnic UniversityNot yet recruitingHearing Loss, Age-Related
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityRecruitingHearing Loss, Sensorineural | Age-related Hearing LossChina
-
Humans MatterNot yet recruitingHearing Loss, Age-Related
-
Institut PasteurCEntre de Recherche et d'Innovation en Audiologie Humaine; Laboratoire de correction...Recruiting
Clinical Trials on Consult Model
-
University of VermontNeurocrine BiosciencesCompletedDrug-Induced Movement DisorderUnited States
-
Radboud University Medical CenterUnknown
-
NYU Langone HealthThe Rainer Arnhold FoundationCompletedCoronary Artery Disease | Hypertension | Obesity | Diabetes | Peripheral Arterial Disease | Hyperlipidemia | PrediabetesUnited States
-
University of VirginiaNamrita OdackalCompletedPremature Birth | Prenatal StressUnited States
-
Turtle Health, Inc.WithdrawnFertility RiskUnited States
-
Seattle Institute for Biomedical and Clinical ResearchMinneapolis Veterans Affairs Medical Center; VA Puget Sound Health Care System and other collaboratorsNot yet recruitingSmoking Cessation | Pneumonia | HIV | Proton Pump Inhibitor | Inhaled CorticosteroidUnited States
-
Massachusetts General HospitalDermatology FoundationCompletedCellulitisUnited States
-
Academisch Medisch Centrum - Universiteit van Amsterdam...CompletedHeart FailureNetherlands
-
PREtest ConsultUnknownAcute Coronary SyndromeUnited States
-
Memorial Sloan Kettering Cancer CenterCompleted